Search Results

You are looking at 21 - 30 of 117 items for :

  • recurrence-free survival x
Clear All
Ashley K Clift Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Ashley K Clift in
Google Scholar
PubMed
Close
,
Oskar Kornasiewicz Department of Surgery and Cancer, Imperial College London, London, UK
Department of Surgery, Warsaw Medical University, Warsaw, Poland

Search for other papers by Oskar Kornasiewicz in
Google Scholar
PubMed
Close
,
Panagiotis Drymousis Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Panagiotis Drymousis in
Google Scholar
PubMed
Close
,
Omar Faiz Department of Surgery, St Mark’s Hospital, London, UK

Search for other papers by Omar Faiz in
Google Scholar
PubMed
Close
,
Harpreet S Wasan Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Harpreet S Wasan in
Google Scholar
PubMed
Close
,
James M Kinross Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by James M Kinross in
Google Scholar
PubMed
Close
,
Thomas Cecil Peritoneal Malignancy Unit, Basingstoke and North Hampshire Hospital, Basingstoke, UK

Search for other papers by Thomas Cecil in
Google Scholar
PubMed
Close
, and
Andrea Frilling Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Andrea Frilling in
Google Scholar
PubMed
Close

Right hemicolectomy 32 DOD 20 50 Appendectomy 3 A, NED 21 55 Right hemicolectomy 4 A, NED *Recurrence at 18 months, but disease free at last follow-up. A, alive; DOD, died of disease; DR

Open access
Yujie Ren Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China

Search for other papers by Yujie Ren in
Google Scholar
PubMed
Close
,
Xue Han Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China

Search for other papers by Xue Han in
Google Scholar
PubMed
Close
,
Yujiang Li Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China

Search for other papers by Yujiang Li in
Google Scholar
PubMed
Close
,
Guofang Chen Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Key Laboratory of TCM Syndrome and Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China

Search for other papers by Guofang Chen in
Google Scholar
PubMed
Close
,
Lin Jiang Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China

Search for other papers by Lin Jiang in
Google Scholar
PubMed
Close
,
Chao Liu Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Key Laboratory of TCM Syndrome and Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China

Search for other papers by Chao Liu in
Google Scholar
PubMed
Close
, and
Shuhang Xu Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China

Search for other papers by Shuhang Xu in
Google Scholar
PubMed
Close

, which was calculated as follows: IAR (%) = Va/preoperative tumor volume × 100%. The primary outcomes included local tumor progression, recurrence-free survival (RFS), and delayed surgery. Local tumor progression was defined as any of the following ( 23

Open access
Ayana Suzuki Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan

Search for other papers by Ayana Suzuki in
Google Scholar
PubMed
Close
,
Mitsuyoshi Hirokawa Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan

Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Close
,
Izumi Otsuka Secretary Section, Kuma Hospital, Kobe, Japan

Search for other papers by Izumi Otsuka in
Google Scholar
PubMed
Close
,
Akihiro Miya Department of Surgery, Kuma Hospital, Kobe, Japan

Search for other papers by Akihiro Miya in
Google Scholar
PubMed
Close
,
Akira Miyauchi Department of Surgery, Kuma Hospital, Kobe, Japan

Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Close
, and
Takashi Akamizu Department of Internal Medicine, Kuma Hospital, Kobe, Japan

Search for other papers by Takashi Akamizu in
Google Scholar
PubMed
Close

) Postoperative outcomes  Follow-up period mean (range) (years) 11.2 (2.7–13.7) 11.5 (2.3–13.8) 12.4 (2.4–13.8) NS NS  Progression free survival rate (10 years) 90.9% 79.6% 95.8% NS NS  Recurrence 9.1% (3) 19

Open access
Samira M Sadowski Thoracic and Endocrine Surgery, University Hospitals of Geneva, Geneva, Switzerland

Search for other papers by Samira M Sadowski in
Google Scholar
PubMed
Close
,
Emanuel Christ Department of Endocrinology, Diabetes and Metabolism, University Hospital of Basel, Basel, Switzerland

Search for other papers by Emanuel Christ in
Google Scholar
PubMed
Close
,
Benoit Bédat Thoracic and Endocrine Surgery, University Hospitals of Geneva, Geneva, Switzerland

Search for other papers by Benoit Bédat in
Google Scholar
PubMed
Close
,
Attila Kollár Department of Medical Oncology, Inselspital, University of Bern, Bern, Switzerland

Search for other papers by Attila Kollár in
Google Scholar
PubMed
Close
,
Wolfram Karenovics Thoracic and Endocrine Surgery, University Hospitals of Geneva, Geneva, Switzerland

Search for other papers by Wolfram Karenovics in
Google Scholar
PubMed
Close
,
Aurel Perren Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed
Close
,
Frédéric Triponez Thoracic and Endocrine Surgery, University Hospitals of Geneva, Geneva, Switzerland

Search for other papers by Frédéric Triponez in
Google Scholar
PubMed
Close
, and
on behalf of the SwissNET registry
Search for other papers by on behalf of the SwissNET registry in
Google Scholar
PubMed
Close

following R0 resection, with no evidence of local recurrence or distant metastasis on imaging. Survival analyses using the Kaplan–Meier method were performed to determine outcomes, and log-rank test was performed for comparison. Statistical analyses were

Open access
Alberto Giacinto Ambrogio Neuroendocrinology Research Laboratory, Istituto Auxologico Italiano IRCCS, Milan, Italy

Search for other papers by Alberto Giacinto Ambrogio in
Google Scholar
PubMed
Close
,
Massimiliano Andrioli Neuroendocrinology Research Laboratory, Istituto Auxologico Italiano IRCCS, Milan, Italy

Search for other papers by Massimiliano Andrioli in
Google Scholar
PubMed
Close
,
Martina De Martin Neuroendocrinology Research Laboratory, Istituto Auxologico Italiano IRCCS, Milan, Italy

Search for other papers by Martina De Martin in
Google Scholar
PubMed
Close
,
Francesco Cavagnini Neuroendocrinology Research Laboratory, Istituto Auxologico Italiano IRCCS, Milan, Italy

Search for other papers by Francesco Cavagnini in
Google Scholar
PubMed
Close
, and
Francesca Pecori Giraldi Neuroendocrinology Research Laboratory, Istituto Auxologico Italiano IRCCS, Milan, Italy
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Francesca Pecori Giraldi in
Google Scholar
PubMed
Close

in others. This has given rise to the search for reliable markers of recurrence ( 1 , 7 ), usually at immediate postsurgical testing, but none has proven fully predictive for long-term, relapse-free survival. One potential recurrence prognostic is

Open access
B C M Hermans Department of Pulmonary Diseases, GROW School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by B C M Hermans in
Google Scholar
PubMed
Close
,
J L Derks Department of Pulmonary Diseases, GROW School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by J L Derks in
Google Scholar
PubMed
Close
,
H J M Groen Department of Pulmonary Diseases, University of Groningen and University Medical Centre, Groningen, The Netherlands

Search for other papers by H J M Groen in
Google Scholar
PubMed
Close
,
J A Stigt Department of Pulmonary Diseases, Isala Hospital, Zwolle, The Netherlands

Search for other papers by J A Stigt in
Google Scholar
PubMed
Close
,
R J van Suylen Pathology-DNA, Jeroen Bosch Hospital, ‘s Hertogenbosch, The Netherlands

Search for other papers by R J van Suylen in
Google Scholar
PubMed
Close
,
L M Hillen Department of Pathology, GROW School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by L M Hillen in
Google Scholar
PubMed
Close
,
E C van den Broek PALGA Foundation, Utrecht, The Netherlands

Search for other papers by E C van den Broek in
Google Scholar
PubMed
Close
,
E J M Speel Department of Pathology, GROW School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by E J M Speel in
Google Scholar
PubMed
Close
, and
A-M C Dingemans Department of Pulmonary Diseases, GROW School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by A-M C Dingemans in
Google Scholar
PubMed
Close

; PFS, progression-free survival; PR, partial response; PY, packyears; RTx, radiotherapy; SRT, stereotactic radiotherapy; WBRT, whole brain radiotherapy. Mean Ki-67 PI was 59% (range 15–100%, Table 2 ). In 6/11 LCNEC Ki-67 PI was ≤40%. Both

Open access
Ashley K Clift Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Ashley K Clift in
Google Scholar
PubMed
Close
,
Omar Faiz Department of Surgery, St Mark’s Hospital, London, UK

Search for other papers by Omar Faiz in
Google Scholar
PubMed
Close
,
Robert Goldin Centre for Pathology, Imperial College London, London, UK

Search for other papers by Robert Goldin in
Google Scholar
PubMed
Close
,
John Martin Department of Gastroenterology, Imperial College London, London, UK

Search for other papers by John Martin in
Google Scholar
PubMed
Close
,
Harpreet Wasan Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Harpreet Wasan in
Google Scholar
PubMed
Close
,
Marc-Olaf Liedke Department of Surgery, Westkuesten Klinikum Heide, Heide, Germany

Search for other papers by Marc-Olaf Liedke in
Google Scholar
PubMed
Close
,
Erik Schloericke Department of Surgery, Westkuesten Klinikum Heide, Heide, Germany

Search for other papers by Erik Schloericke in
Google Scholar
PubMed
Close
,
Anna Malczewska Department of Surgery and Cancer, Imperial College London, London, UK
Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland

Search for other papers by Anna Malczewska in
Google Scholar
PubMed
Close
,
Guido Rindi Institute of Anatomic Pathology, Universita Cattolica del Sacro Cuore, Rome, Italy

Search for other papers by Guido Rindi in
Google Scholar
PubMed
Close
,
Mark Kidd Wren Laboratories, Branford, Connecticut, USA

Search for other papers by Mark Kidd in
Google Scholar
PubMed
Close
,
Irvin M Modlin Emeritus Professor Gastrointestinal Surgery, School of Medicine, Yale University, New Haven, Connecticut, USA

Search for other papers by Irvin M Modlin in
Google Scholar
PubMed
Close
, and
Andrea Frilling Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Andrea Frilling in
Google Scholar
PubMed
Close

. Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable prognostic factors in patients from nrg oncology/gynecologic oncology group randomized

Open access
Logan Mills Institute of Liver Studies, King’s College Hospital, London, UK

Search for other papers by Logan Mills in
Google Scholar
PubMed
Close
,
Panagiotis Drymousis Department of Surgery and Cancer, Imperial College, London, UK

Search for other papers by Panagiotis Drymousis in
Google Scholar
PubMed
Close
,
Yogesh Vashist Department of General, Visceral and Thoracic Surgery, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany

Search for other papers by Yogesh Vashist in
Google Scholar
PubMed
Close
,
Christoph Burdelski Department of General, Visceral and Thoracic Surgery, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany

Search for other papers by Christoph Burdelski in
Google Scholar
PubMed
Close
,
Andreas Prachalias Department of Surgery, King’s College Hospital, London, UK

Search for other papers by Andreas Prachalias in
Google Scholar
PubMed
Close
,
Parthi Srinivasan Department of Surgery, King’s College Hospital, London, UK

Search for other papers by Parthi Srinivasan in
Google Scholar
PubMed
Close
,
Krishna Menon Department of Surgery, King’s College Hospital, London, UK

Search for other papers by Krishna Menon in
Google Scholar
PubMed
Close
,
Corina Cotoi Department of Histopathology, King’s College Hospital, London, UK

Search for other papers by Corina Cotoi in
Google Scholar
PubMed
Close
,
Saboor Khan Department of Surgery, University Hospitals Coventry and Warwickshire, Coventry, UK

Search for other papers by Saboor Khan in
Google Scholar
PubMed
Close
,
Judith Cave Department of Oncology, University Hospital, Southampton, UK

Search for other papers by Judith Cave in
Google Scholar
PubMed
Close
,
Thomas Armstrong Department of Surgery, University Hospital, Southampton, UK

Search for other papers by Thomas Armstrong in
Google Scholar
PubMed
Close
,
Martin O Weickert Department of Endocrinology, University Hospitals Coventry and Warwickshire, Coventry, UK

Search for other papers by Martin O Weickert in
Google Scholar
PubMed
Close
,
Jakob Izbicki Department of General, Visceral and Thoracic Surgery, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany

Search for other papers by Jakob Izbicki in
Google Scholar
PubMed
Close
,
Joerg Schrader Departments of Gastroenterology and Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Search for other papers by Joerg Schrader in
Google Scholar
PubMed
Close
,
Andreja Frilling Department of Surgery and Cancer, Imperial College, London, UK

Search for other papers by Andreja Frilling in
Google Scholar
PubMed
Close
,
John K Ramage Institute of Liver Studies, King’s College Hospital, London, UK

Search for other papers by John K Ramage in
Google Scholar
PubMed
Close
, and
Raj Srirajaskanthan Institute of Liver Studies, King’s College Hospital, London, UK

Search for other papers by Raj Srirajaskanthan in
Google Scholar
PubMed
Close

.005; *** P  < 0.001. HR, hazard ratio; LNR, lymph node ratio; PFS, progression-free survival. Progression was defined by local recurrence, new or progressive metastases or death ( Table 4 ). The 11 cases of local recurrence were associated

Open access
Guoquan Zhu Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Guoquan Zhu in
Google Scholar
PubMed
Close
,
Yuying Deng Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Yuying Deng in
Google Scholar
PubMed
Close
,
Liqin Pan Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Liqin Pan in
Google Scholar
PubMed
Close
,
Wei Ouyang Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Close
,
Huijuan Feng Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Close
,
Juqing Wu Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Juqing Wu in
Google Scholar
PubMed
Close
,
Pan Chen Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Pan Chen in
Google Scholar
PubMed
Close
,
Jing Wang Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Jing Wang in
Google Scholar
PubMed
Close
,
Yanying Chen Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Yanying Chen in
Google Scholar
PubMed
Close
, and
Jiaxin Luo Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Close

well as those with various subtypes of PTC. In addition, the BRAF V600E mutation was associated with poorer recurrence-free probability in Kaplan–Meier survival analyses in various clinicopathologic categories. Thus, the author suggested that the

Open access
Wentao Zhou The Research Institution of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Wentao Zhou in
Google Scholar
PubMed
Close
,
Tiantao Kuang The Research Institution of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Close
,
Xu Han Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Xu Han in
Google Scholar
PubMed
Close
,
Wenqi Chen Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Wenqi Chen in
Google Scholar
PubMed
Close
,
Xuefeng Xu The Research Institution of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Close
,
Wenhui Lou Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Wenhui Lou in
Google Scholar
PubMed
Close
, and
Dansong Wang The Research Institution of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Dansong Wang in
Google Scholar
PubMed
Close

dynamic enhanced CT or MRI. The primary outcome of this research is relapse-free survival (RFS), which was determined by the interval between the day of operation and the date of relapse or last follow-up. Similarly, overall survival (OS) was defined as

Open access